Concentra Group Holdings Parent vs Haemonetics

Concentra Group Holdings Parent (CON), health care, and Haemonetics (HAE), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Haemonetics is worth $5.5B on the stock market and Concentra Group Holdings Parent $5.3B: Haemonetics is valued at 3% more. Concentra Group Holdings Parent trades at 25.1 times earnings and Haemonetics at 53.6; operating margins in their latest fiscal years were 15.4% and 11.7%. Over the past year Concentra Group Holdings Parent's share price has moved +126% and Haemonetics's +63.1%.

Key facts

Concentra Group Holdings Parent market value
$5.3B
Haemonetics market value
$5.5B
Concentra Group Holdings Parent P/E
25.1
Haemonetics P/E
53.6
Concentra Group Holdings Parent revenue
$2.2BFY to 2025-12-31
Haemonetics revenue
$1.3BFY to 2026-03-28
Superinvestors holding both
0

Market values as of .

Concentra Group Holdings Parent vs Haemonetics: every measure side by side
Measure Concentra Group Holdings Parent Haemonetics
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312026-03-28
Size
Market cap$5.3Blower$5.5Bhigher
Revenue$2.2Bhigher$1.3Blower
Earnings$166.4Mhigher$97.3Mlower
Employees9,967higher3,009lower
Total assets$2.9Bhigher$2.4Blower
Valuation
P/E25.1lower53.6higher
P/S2.5lower4.1higher
P/B10.6higher6.1lower
Dividend yield0.58%higher0.00%lower
Profitability
Operating margin15.4%higher11.7%lower
Balance sheet
Net assets$393.3Mlower$796.3Mhigher
Total liabilities$2.4Bhigher$1.6Blower
Total debt$1.6Bhigher$1.2Blower
Cash on hand$79.9Mlower$245.4Mhigher
Price change
Today-2.30%lower-0.21%higher
1 year+126%higher+63.1%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Concentra Group Holdings Parent only (2)

Haemonetics only (1)

Percentages are each holding's share of that investor's reported portfolio. Who owns CON · Who owns HAE

Further comparisons

Learn

Questions and answers

Which is bigger, Concentra Group Holdings Parent or Haemonetics?

By market value, Haemonetics is the larger: $5.5B against $5.3B for Concentra Group Holdings Parent. By revenue in its latest fiscal year, Concentra Group Holdings Parent is the larger: $2.2B against $1.3B for Haemonetics.

Which has the higher P/E ratio?

Haemonetics: 53.6, against 25.1 for Concentra Group Holdings Parent. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Concentra Group Holdings Parent: 15.4%, against 11.7% for Haemonetics. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Concentra Group Holdings Parent: 0.58%, against 0.00% for Haemonetics. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Concentra Group Holdings Parent: $1.6B, against $1.2B for Haemonetics. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Concentra Group Holdings Parent and Haemonetics?

None of the tracked superinvestors holds both in their latest 13F filing. 2 hold Concentra Group Holdings Parent and 1 holds Haemonetics.

Cite this page

Funkfolio, “Concentra Group Holdings Parent vs Haemonetics”, data as of 17 November 2026. https://funkfolio.com/compare/con-vs-hae

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.